Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 838 results for "mylan"

Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR To Apotex; Apotex Can No Longer Supply Authorized Generic Product

Mylan receives motion for permanent injunction against GSK for...

(MarketLine via COMTEX News Network) -- Mylan Inc., a generic pharmaceutical company, has received motion for a permanent injunction against GlaxoSmithKline, or GSK, from the US District Court for the District of New Jersey in relation to Paroxetine ... PredictWallStreet, 9 hours ago
Mylan wins suit over generic Paxil Seeking Alpha, 5 days ago

245 images for mylan

RCL Advisors, 5 days ago, 1 week ago
Bidness Etc, 1 week ago
Business Today India, 1 week ago
MassDevice, 1 week ago
Fidelity Brokerage Services LLC, 1 week ago
International Business Times India, 6 days ago
Bidness Etc, 1 week ago, 1 week ago
Yahoo! News Australia, 6 days ago
International Business Times India

Top 10 Pharma Deals in Last Five Years

Reuters On Monday, 14 July, Pharmaceutical Company Mylan Inc announced the acquisition of Abbott Laboratories in markets outside the United States, with an aim to cut their tax bill using tax inversion methods. In the past too many such deals ...
 International Business Times India4 days ago MYLAN : More Tax Inversions: Abbott Selling Part of Generic Drug Business to Mylan for $5.3 Billion  4 Traders4 days ago EDITORIAL: Taxes push patriotic companies overseas [Charleston Daily Mail, W.Va. :: ]  Pharmacy Choice5 days ago Generic Drugmaker Mylan Inc to Acquire Abbott Labs for $5.3 billion through Tax Inversion  International Business Times India6 days ago
Business Standard

Cipla, Mylan, Micro Labs, Aurobindo, Emcure ink licensing pact for antiretrovirals with a UN unit

Medicines Patent Pool has signed seven new sub-licences for generic HIV medicines with Cipla, Mylan, Micro Labs, Aurobindo, Laurus Labs, Emcure and Desano (a Chinese manufacturer) BS B2B Bureau | Mumbai July 17, 2014 Last Updated at 16:48 IST Medicines Patent ...
 Business Standard5 days ago MPP announces 7 new sub-licensing agreements for manufacture of generic HIV medicines  News-Medical.Net5 days ago The Medicines Patent Pool Signs a Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries  Crawford Financial Planning5 days ago MPP signs seven sub-licensing agreements to manufacture HIV medicines  Express Pharma5 days ago

Sanofi May Sell 200 Mature Drugs; Abbott, Mylan Potential Buyers

According to a 25-page document internal document reviewed by Reuters, French drugmaker Sanofi has held talks with Abbott Labs, Mylan and private equity firms regarding the possible sale of an $8.5 billion portfolio of mature drugs. The document ...
 Pharmaceutical Manufacturing Magazine5 days ago Sanofi held talks with Abbott, Mylan for mature products sale  Livemint.com6 days ago Sanofi may join Abbott-Mylan deal  Pharma In Focus5 days ago Sanofi (France) Quietly Held Talks With Abbott Laboratories, Mylan Inc. About Mature Drugs  BioSpace6 days ago

Mylan to appeal EC anti-trust findings against Matrix

Drugmaker Mylan will appeal the European Commisions recent anti-trust findings and fine imposed on its subsidiary, the erstwhile Matrix Laboratories. The decision relates to a settlement agreement entered into by Matrix with Les Laboratoires Servier in 2005 ...
 Business Line1 week ago EC slaps fine on Lupin, Unichem Labs, Mylan Unit  Economic Times1 week ago

UK says Mylan recalls batches of Indian-made antibiotic

LONDON (Reuters) - U.S. drugmaker Mylan is recalling batches of the injectable antibiotic clarithromycin made in India due to possible impurities, Britain's healthcare regulator said on Wednesday. The Medicines and Healthcare products Regulatory Agency, or ...
 Business Standard1 month ago UK says Mylan recalls batches of Polish-made antibiotic  Reuters1 month ago Corrected - UK says Mylan recalls batches of Polish-made antibiotic  Business Standard1 month ago

India Inc's foreign borrowings fall to $ 1.46 billion in May

General Motors India raised $ 244.50 million for general corporate purpose (11.8 years) and Mylan Laboratories borrowed $ 200 million. MUMBAI: External borrowings of Indian companies fell by 41.3 per cent to $ 1.46 billion in May this year compared to the ...
 Economic Times2 weeks ago

Wockhardt denies media report on asset sale talks

MUMBAI (Reuters) - Generic drugmaker Wockhardt Ltd denied on Tuesday a media report that said U.S. drugmakers Mylan Inc and Pfizer Inc were in talks with the company to buy some of its assets. Wockhardt cited the media report as saying that Mylan was in talks ...
 Reuters2 months ago

Rajiv Malik, President, Mylan

We are very well positioned to continue to do what we do best in 2014, which is leverage our one-of-a-kind platform, execute relentlessly across our business Manav Rachna International University offers a Career in Physiotherapy New Exim Policy to promote ...
 India Infoline2 months ago

Next Resistance Level for Mylan (MYL) is $52.16

Shares of Mylan (NASDAQ:MYL) have bullishly opened above the pivot of $51.45 today and have reached the first resistance level of $51.77. Analysts will be watching for a cross of the next upside pivot targets of $52.16
 Individual.com2 hours ago Mylan Laboratories (MYL) Trading Near $50.74 Support Level  Individual.com4 hours ago Mylan Laboratories (MYL) Showing Bullish Technicals With Resistance At $52.13  Individual.com4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - mylan
Get updated on latest news & your favorite topics right in your inbox!
More     Less